ID BEST3_HUMAN Reviewed; 668 AA. AC Q8N1M1; B5MDI8; F8VVZ2; Q53YQ7; Q8N356; Q8NFT9; Q9BR80; DT 21-NOV-2003, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-2002, sequence version 1. DT 27-MAR-2024, entry version 168. DE RecName: Full=Bestrophin-3; DE AltName: Full=Vitelliform macular dystrophy 2-like protein 3; GN Name=BEST3; Synonyms=VMD2L3; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY. RX PubMed=12032738; DOI=10.1038/sj.ejhg.5200796; RA Stoehr H., Marquardt A., Nanda I., Schmid M., Weber B.H.F.; RT "Three novel human VMD2-like genes are members of the evolutionary highly RT conserved RFP-TM family."; RL Eur. J. Hum. Genet. 10:281-284(2002). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION. RX PubMed=12907679; DOI=10.1074/jbc.m306150200; RA Tsunenari T., Sun H., Williams J., Cahill H., Smallwood P., Yau K.-W., RA Nathans J.; RT "Structure-function analysis of the bestrophin family of anion channels."; RL J. Biol. Chem. 278:41114-41125(2003). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Tongue; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16541075; DOI=10.1038/nature04569; RA Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y., RA Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C., RA Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C., RA Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., RA Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E., RA Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., RA Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., RA Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., RA Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., RA Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., RA Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., RA Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., RA Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., RA Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., RA Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K., RA Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D., RA Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R., RA David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E., RA D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N., RA Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N., RA Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R., RA Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S., RA LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H., RA Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P., RA Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G., RA Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E., RA Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S., RA Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., RA Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J., RA Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A., RA Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M., RA Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I., RA Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A., RA Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y., RA Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A., RA Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F., RA Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L., RA Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G., RA Gibbs R.A.; RT "The finished DNA sequence of human chromosome 12."; RL Nature 440:346-351(2006). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 6). RC TISSUE=Lymph; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). CC -!- FUNCTION: Forms calcium-sensitive chloride channels. Permeable to CC bicarbonate. {ECO:0000269|PubMed:12907679}. CC -!- INTERACTION: CC Q8N1M1-5; O15499: GSC2; NbExp=3; IntAct=EBI-20140863, EBI-19954058; CC -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=5; CC Name=2; CC IsoId=Q8N1M1-2; Sequence=Displayed; CC Name=1; CC IsoId=Q8N1M1-1; Sequence=VSP_008977, VSP_008978; CC Name=4; CC IsoId=Q8N1M1-4; Sequence=VSP_008981, VSP_008982, VSP_008983; CC Name=5; CC IsoId=Q8N1M1-5; Sequence=VSP_046979, VSP_046980; CC Name=6; CC IsoId=Q8N1M1-6; Sequence=VSP_008981; CC -!- TISSUE SPECIFICITY: Present in skeletal muscle and weakly in brain, CC spinal cord, bone marrow and retina. {ECO:0000269|PubMed:12032738}. CC -!- SIMILARITY: Belongs to the anion channel-forming bestrophin (TC 1.A.46) CC family. Calcium-sensitive chloride channel subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF440758; AAM76997.1; -; mRNA. DR EMBL; AY515706; AAR99656.1; -; mRNA. DR EMBL; AK096459; BAC04797.1; -; mRNA. DR EMBL; AC016153; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC018921; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC025263; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC151138; -; NOT_ANNOTATED_CDS; mRNA. DR EMBL; BC006440; AAH06440.1; -; mRNA. DR CCDS; CCDS41810.1; -. [Q8N1M1-5] DR CCDS; CCDS61192.1; -. [Q8N1M1-6] DR CCDS; CCDS61193.1; -. [Q8N1M1-1] DR CCDS; CCDS73496.1; -. [Q8N1M1-4] DR CCDS; CCDS8992.2; -. [Q8N1M1-2] DR RefSeq; NP_001269542.1; NM_001282613.1. [Q8N1M1-6] DR RefSeq; NP_001269543.1; NM_001282614.1. [Q8N1M1-1] DR RefSeq; NP_001269544.1; NM_001282615.1. [Q8N1M1-4] DR RefSeq; NP_001269545.1; NM_001282616.1. [Q8N1M1-4] DR RefSeq; NP_116124.2; NM_032735.2. [Q8N1M1-2] DR RefSeq; NP_689652.2; NM_152439.3. [Q8N1M1-5] DR RefSeq; XP_011536263.1; XM_011537961.1. [Q8N1M1-6] DR AlphaFoldDB; Q8N1M1; -. DR SMR; Q8N1M1; -. DR BioGRID; 126854; 1. DR IntAct; Q8N1M1; 2. DR STRING; 9606.ENSP00000332413; -. DR TCDB; 1.A.46.1.8; the anion channel-forming bestrophin (bestrophin) family. DR iPTMnet; Q8N1M1; -. DR PhosphoSitePlus; Q8N1M1; -. DR BioMuta; BEST3; -. DR DMDM; 38503351; -. DR MassIVE; Q8N1M1; -. DR PaxDb; 9606-ENSP00000332413; -. DR PeptideAtlas; Q8N1M1; -. DR ProteomicsDB; 28912; -. DR ProteomicsDB; 6178; -. DR ProteomicsDB; 71617; -. [Q8N1M1-2] DR ProteomicsDB; 71618; -. [Q8N1M1-1] DR ProteomicsDB; 71619; -. [Q8N1M1-4] DR Antibodypedia; 29432; 336 antibodies from 27 providers. DR DNASU; 144453; -. DR Ensembl; ENST00000266661.8; ENSP00000266661.4; ENSG00000127325.19. [Q8N1M1-4] DR Ensembl; ENST00000330891.10; ENSP00000332413.5; ENSG00000127325.19. [Q8N1M1-2] DR Ensembl; ENST00000331471.8; ENSP00000329064.4; ENSG00000127325.19. [Q8N1M1-1] DR Ensembl; ENST00000488961.5; ENSP00000433213.1; ENSG00000127325.19. [Q8N1M1-5] DR Ensembl; ENST00000551160.5; ENSP00000449377.1; ENSG00000127325.19. [Q8N1M1-4] DR Ensembl; ENST00000553096.5; ENSP00000449548.1; ENSG00000127325.19. [Q8N1M1-6] DR GeneID; 144453; -. DR KEGG; hsa:144453; -. DR MANE-Select; ENST00000330891.10; ENSP00000332413.5; NM_032735.3; NP_116124.2. DR UCSC; uc001svd.4; human. [Q8N1M1-2] DR AGR; HGNC:17105; -. DR CTD; 144453; -. DR DisGeNET; 144453; -. DR GeneCards; BEST3; -. DR HGNC; HGNC:17105; BEST3. DR HPA; ENSG00000127325; Group enriched (skeletal muscle, tongue). DR MIM; 607337; gene. DR neXtProt; NX_Q8N1M1; -. DR OpenTargets; ENSG00000127325; -. DR PharmGKB; PA162377503; -. DR VEuPathDB; HostDB:ENSG00000127325; -. DR eggNOG; KOG3547; Eukaryota. DR GeneTree; ENSGT00940000157777; -. DR HOGENOM; CLU_018069_0_1_1; -. DR InParanoid; Q8N1M1; -. DR OMA; DWLWNYE; -. DR OrthoDB; 2871698at2759; -. DR PhylomeDB; Q8N1M1; -. DR TreeFam; TF315803; -. DR PathwayCommons; Q8N1M1; -. DR Reactome; R-HSA-2672351; Stimuli-sensing channels. DR SignaLink; Q8N1M1; -. DR BioGRID-ORCS; 144453; 10 hits in 1129 CRISPR screens. DR ChiTaRS; BEST3; human. DR GenomeRNAi; 144453; -. DR Pharos; Q8N1M1; Tbio. DR PRO; PR:Q8N1M1; -. DR Proteomes; UP000005640; Chromosome 12. DR RNAct; Q8N1M1; Protein. DR Bgee; ENSG00000127325; Expressed in tibialis anterior and 119 other cell types or tissues. DR ExpressionAtlas; Q8N1M1; baseline and differential. DR GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW. DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW. DR GO; GO:0043271; P:negative regulation of monoatomic ion transport; IEA:Ensembl. DR InterPro; IPR000615; Bestrophin. DR InterPro; IPR021134; Bestrophin-like. DR PANTHER; PTHR10736; BESTROPHIN; 1. DR PANTHER; PTHR10736:SF0; BESTROPHIN-3; 1. DR Pfam; PF01062; Bestrophin; 1. DR Genevisible; Q8N1M1; HS. PE 1: Evidence at protein level; KW Alternative splicing; Calcium; Cell membrane; Chloride; Chloride channel; KW Ion channel; Ion transport; Membrane; Reference proteome; Transmembrane; KW Transmembrane helix; Transport. FT CHAIN 1..668 FT /note="Bestrophin-3" FT /id="PRO_0000143121" FT TOPO_DOM 1..25 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 26..46 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 47..70 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 71..91 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 92..178 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 179..199 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 200..228 FT /note="Extracellular" FT /evidence="ECO:0000255" FT INTRAMEM 229..249 FT /evidence="ECO:0000255" FT TOPO_DOM 250..270 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 271..291 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 292..668 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT REGION 400..454 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 473..493 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 532..570 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 400..416 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 532..550 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT VAR_SEQ 1..162 FT /note="Missing (in isoform 5)" FT /evidence="ECO:0000305" FT /id="VSP_046979" FT VAR_SEQ 1..106 FT /note="Missing (in isoform 4 and isoform 6)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_008981" FT VAR_SEQ 161..178 FT /note="GFMTTDERKLFNHLKSPH -> ERTGMKPILPSSFEMQSF (in isoform FT 4)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_008982" FT VAR_SEQ 179..668 FT /note="Missing (in isoform 4)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_008983" FT VAR_SEQ 239..289 FT /note="Missing (in isoform 5)" FT /evidence="ECO:0000305" FT /id="VSP_046980" FT VAR_SEQ 368..398 FT /note="LSGSDFPDEEWLWDYEKHGHRHSMIRRVKRF -> KQMPKNEWKMEDIKIPL FT PQPQFQCAKSDPGG (in isoform 1)" FT /evidence="ECO:0000303|PubMed:12032738, FT ECO:0000303|PubMed:12907679" FT /id="VSP_008977" FT VAR_SEQ 399..668 FT /note="Missing (in isoform 1)" FT /evidence="ECO:0000303|PubMed:12032738, FT ECO:0000303|PubMed:12907679" FT /id="VSP_008978" FT VARIANT 43 FT /note="Y -> H (in dbSNP:rs1025016)" FT /id="VAR_048409" FT VARIANT 622 FT /note="E -> G (in dbSNP:rs17106884)" FT /id="VAR_048410" SQ SEQUENCE 668 AA; 76107 MW; FDCBD7154C402EA2 CRC64; MTVTYSSKVA NATFFGFHRL LLKWRGSIYK LLYREFIVFA VLYTAISLVY RLLLTGVQKR YFEKLSIYCD RYAEQIPVTF VLGFYVTLVV NRWWNQFVNL PWPDRLMFLI SSSVHGSDEH GRLLRRTLMR YVNLTSLLIF RSVSTAVYKR FPTMDHVVEA GFMTTDERKL FNHLKSPHLK YWVPFIWFGN LATKARNEGR IRDSVDLQSL MTEMNRYRSW CSLLFGYDWV GIPLVYTQVV TLAVYTFFFA CLIGRQFLDP TKGYAGHDLD LYIPIFTLLQ FFFYAGWLKV AEQLINPFGE DDDDFETNWC IDRNLQVSLL AVDEMHMSLP KMKKDIYWDD SAARPPYTLA AADYCIPSFL GSTVQMGLSG SDFPDEEWLW DYEKHGHRHS MIRRVKRFLS AHEHPSSPRR RSYRRQTSDS SMFLPRDDLS PARDLLDVPS RNPPRASPTW KKSCFPEGSP TLHFSMGELS TIRETSQTST LQSLTPQSSV RTSPIKMPLV PEVLITAAEA PVPTSGGYHH DSATSILSSE FTGVQPSKTE QQQGPMGSIL SPSEKETPPG GPSPQTVSAS AEENIFNCEE DPGDTFLKRW SLPGFLGSSH TSLGNLSPDP MSSQPALLID TETSSEISGI NIVAGSRVSS DMLYLMENLD TKETDIIELN KETEESPK //